FindTrial
Sign In

Using the CHUBA score to predict how severe community acquired pneumonia is a prospective study

CHUBA Scoring System for Prognostic Prediction of Community-Acquired Pneumonia- A Prospective Cohort Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/04/108323
Enrollment
100
Registered
2026-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J159- Unspecified bacterial pneumonia

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Anand Basappa Kamakar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: qelkdjajefhjwfhjwaebweh

Exclusion criteria

Exclusion criteria: Age below 18 years Unwilling or unable to provide informed consent Hospital acquired pneumonia Terminal stages of active cancer and Other pulmonary infiltrative disease such as radiation pneumonitis organizing pneumonia drug induce pneumonia active lung cancer tuberculosis fungal infection and empyema

Design outcomes

Primary

MeasureTime frame
This study evaluates the CHUBA index as a prognostic tool in community-acquired pneumonia and compares its performance with CURB-65 and PSI. It aims to identify patient subgroups, especially older adults, where CHUBA provides better predictive accuracy, thereby improving risk stratification and clinical decision-making.Timepoint: Baseline (within 24 hours of admission), Day 7 (or at discharge, whichever is earlier) and 30 days post-admission—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactDr Anwar Mujawar

Jawaharlal Nehru Medical College, Belagavi, KLE university

2anwarhusen@gmail.com9591493007

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026